BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27587705)

  • 1. The 5-HT1A Receptor PET Radioligand 11C-CUMI-101 Has Significant Binding to α1-Adrenoceptors in Human Cerebellum, Limiting Its Use as a Reference Region.
    Shrestha SS; Liow JS; Jenko K; Ikawa M; Zoghbi SS; Innis RB
    J Nucl Med; 2016 Dec; 57(12):1945-1948. PubMed ID: 27587705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
    Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
    J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.
    Kumar JS; Parsey RV; Kassir SA; Majo VJ; Milak MS; Prabhakaran J; Simpson NR; Underwood MD; Mann JJ; Arango V
    Brain Res; 2013 Apr; 1507():11-8. PubMed ID: 23454434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET.
    Milak MS; Severance AJ; Ogden RT; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2008 Apr; 49(4):587-96. PubMed ID: 18344443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer.
    Milak MS; DeLorenzo C; Zanderigo F; Prabhakaran J; Kumar JS; Majo VJ; Mann JJ; Parsey RV
    J Nucl Med; 2010 Dec; 51(12):1892-900. PubMed ID: 21098796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes.
    Orlandini E; Rapposelli S; Nencetti S; Giannaccini G; Betti L; Balsamo A
    Arch Pharm (Weinheim); 2007 Mar; 340(3):135-9. PubMed ID: 17335104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging.
    Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C
    Nucl Med Biol; 2013 Aug; 40(6):747-54. PubMed ID: 23810488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No change in [¹¹C]CUMI-101 binding to 5-HT(1A) receptors after intravenous citalopram in human.
    Pinborg LH; Feng L; Haahr ME; Gillings N; Dyssegaard A; Madsen J; Svarer C; Yndgaard S; Kjaer TW; Parsey RV; Hansen HD; Ettrup A; Paulson OB; Knudsen GM
    Synapse; 2012 Oct; 66(10):880-4. PubMed ID: 22730164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vivo evaluation of a novel 5-HT1A receptor agonist radioligand [O-methyl- 11C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione in nonhuman primates.
    Kumar JS; Prabhakaran J; Majo VJ; Milak MS; Hsiung SC; Tamir H; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1050-60. PubMed ID: 17221184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
    Hirvonen J; Kajander J; Allonen T; Oikonen V; Någren K; Hietala J
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):185-95. PubMed ID: 16685258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS; Majo VJ; Hsiung SC; Millak MS; Liu KP; Tamir H; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    J Med Chem; 2006 Jan; 49(1):125-34. PubMed ID: 16392798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.
    Majo VJ; Milak MS; Prabhakaran J; Mali P; Savenkova L; Simpson NR; Mann JJ; Parsey RV; Kumar JS
    Bioorg Med Chem; 2013 Sep; 21(17):5598-604. PubMed ID: 23816046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different affinities of native alpha1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations.
    Sathi ZS; Anisuzzaman AS; Morishima S; Suzuki F; Tanaka T; Yoshiki H; Muramatsu I
    Eur J Pharmacol; 2008 Apr; 584(2-3):222-8. PubMed ID: 18336813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissue.
    Hendry N; Christie I; Rabiner EA; Laruelle M; Watson J
    Nucl Med Biol; 2011 Feb; 38(2):273-7. PubMed ID: 21315283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography.
    Parsey RV; Arango V; Olvet DM; Oquendo MA; Van Heertum RL; John Mann J
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):785-93. PubMed ID: 15716853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
    Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
    Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.
    Hines CS; Liow JS; Zanotti-Fregonara P; Hirvonen J; Morse C; Pike VW; Innis RB
    PLoS One; 2011; 6(9):e25309. PubMed ID: 21980419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [11C]RN5: a new agent for the in vivo imaging of myocardial alpha1-adrenoceptors.
    Matarrese M; Moresco RM; Romeo G; Turolla EA; Simonelli P; Todde S; Belloli S; Carpinelli A; Magni F; Russo F; Galli Kienle M; Fazio F
    Eur J Pharmacol; 2002 Oct; 453(2-3):231-8. PubMed ID: 12398909
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.